Verdence Capital Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-14,016
Closed -$330K 547
2023
Q1
$330K Sell
14,016
-3,141
-18% -$84.3K 0.04% 390
2022
Q4
$479K Sell
17,157
-5,963
-26% -$152K 0.06% 287
2022
Q3
$541K Sell
23,120
-4,846
-17% -$146K 0.07% 255
2022
Q2
$944K Sell
27,966
-255
-0.9% -$8.93K 0.12% 184
2022
Q1
$986K Sell
28,221
-17
-0.1% -$581 0.11% 196
2021
Q4
$860K Buy
28,238
+652
+2% +$21.2K 0.1% 199
2021
Q3
$905K Buy
+27,586
New +$883K 0.12% 181

Other funds holding OGN

Verdence Capital Advisors's OGN Position: Q2 2023 in Review

Verdence Capital Advisors sold out of Organon & Co (OGN) in Q2 2023, closing a stake of 14,016 shares — an estimated $330K sold.

Verdence Capital Advisors first reported a position in OGN in Q3 2021 and held it in 7 quarters. The position peaked at $986K in Q1 2022. 726 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

  • Verdence Capital Advisors reported no remaining Organon & Co position as of Q2 2023 after selling out during the quarter.
  • Verdence Capital Advisors sold 14,016 Organon & Co shares in Q2 2023, an estimated $330K.
  • Verdence Capital Advisors first reported a position in Organon & Co in Q3 2021 and held it in 7 quarters.
  • Verdence Capital Advisors's Organon & Co position peaked at $986K in Q1 2022.
  • 726 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on Verdence Capital Advisors's 13F filing for Q2 2023, filed 31 Jul 2023.